Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
一项针对重症流感患者的法匹拉韦(T-705)联合奥司他韦的2a期、开放标签、剂量递增、多中心药代动力学研究
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2020.103125
Wang, Yeming; Zhong, Wu; Salam, Alex; Tarning, Joel; Zhan, Qingyuan; Huang, Jian-An; Weng, Heng; Bai, Changqing; Ren, Yanhong; Yamada, Koichi; Wang, Dayan; Guo, Qiang; Fang, Qiongqiong; Tsutomu, Sakurai; Zou, Xiaohui; Li, Haibo; Gillesen, Annelies; Castle, Lyndsey; Chen, Cheng; Li, Hongyan; Zhen, Jing; Lu, Binghuai; Duan, Jun; Guo, Liping; Jiang, Jinfang; Cao, Ruiyuan; Fan, Guohui; Li, Jintong; Hayden, Frederick G; Wang, Chen; Horby, Peter; Cao, Bin